drugset / Trial / NCT03492697
A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961
RandomizedCrossoverOpen-labelBasic science
Summary
This open label study will evaluate the pharmacokinetics (PK) following single oral doses of different formulations of PF-06882961, including controlled release (CR) tablets at 2 release rates (long and short duration), an immediate release (IR) oral solution, and IR tablets, in healthy adult subjects.
Timeline
- Start
- 2018-04-30
- Primary completion
- 2018-07-18
- Completion
- 2018-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danuglipron | Small molecule | — | Oral |
Indications
No indication recorded.